Since the Covid pandemic, medtech companies have placed greater expectations on their medical device manufacturers, driven by the need to bring devices to market more quickly. Consequently, the ...

PFE faces COVID revenue declines and a patent cliff, but new products, acquisitions and a strong pipeline could fuel growth ...

The COVID-19 pandemic may be viewed as the single largest disruptor in the history of American healthcare. At Geisinger, the crisis has been a catalyst to accelerate digital transformation. In January ...

The US Food and Drug Administration (FDA) on Monday evening issued two guidances intended to accelerate the development of products to treat or prevent coronavirus disease (COVID-19), laying out ...

The Strategic and Economic Impact of COVID-19 on Associations, a report published last month by Association Laboratory, Inc., points to a shift from traditional membership models to more digital ones.